Betahistine metabolites, Aminoethylpyridine, and Hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo

International Journal of Audiology

Volumn 53, Issue 10, 2014, Pages 753-759

  Bertlich, Mattis ^a,b   Ihler, Fritz ^a,b   Sharaf, Kariem ^b   Weiss, Bernhard G ^a   Strupp, Michael ^b   Canis, Martin ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Aminoethylpyridine; Betahistine; Cochlear blood flow; Histamine; Hydroxyethylpyridine; M ni re's disease; Pyridylacetic acid

Indexed keywords

2-(2-AMINOETHYL)PYRIDINE; 2-(2-HYDROXYETHYL)PYRIDINE; 2-PYRIDYLACETIC ACID; ACETIC ACID DERIVATIVE; BETAHISTINE; HISTAMINE AGONIST; PYRIDINE DERIVATIVE;

ANIMAL; BLOOD PRESSURE; COCHLEA; DRUG EFFECTS; GUINEA PIG; MENIERE DISEASE; METABOLISM; MICROCIRCULATION; RANDOMIZATION; VASCULARIZATION;

ACETATES; ANIMALS; BETAHISTINE; BLOOD PRESSURE; COCHLEA; GUINEA PIGS; HISTAMINE AGONISTS; MENIERE DISEASE; MICROCIRCULATION; PYRIDINES; RANDOM ALLOCATION;

EID: 84907058265     PISSN: 14992027     EISSN: 17088186     Source Type: Journal    
DOI: 10.3109/14992027.2014.917208     Document Type: Article

References (45)

1. Arpornchayanon W., Canis M., Ihler F., Settevendemie C. & Strieth S. 2013. TNF-alpha inhibition using etanercept prevents no ise-induced hearing loss by improvement of cochlear blood flow in vivo. Int J Audiol, 52, 545-552.
2. Baker M. & Wayland H. 1974. On-line volume flow rate and velocity profi le measurement for blood in microvessels. Microvasc Res, 7, 131-143.
3. Boles R., Rice D.H., Hybels R. & Work W.P. 1975. Conservative management of Ménière ' s disease: Furstenberg regimen revisited. Ann Otol Rhinol Laryngol, 84, 513-517.
4. Botta L., Mira E., Valli S., Zucca G., Benvenuti C. et al. 2001. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital, 21, 24-30.
5. Botta L., Mira E., Valli S., Zucca G., Perin P. et al. 2000. Effects of betahistine metabolites on frog ampullar receptors. Acta Otolaryngol, 120, 25-27.
6. Bowman F.J.,Bowman E.R.,McKennis Jr. H. 1972. Possible alternate routes in the metabolism of betahistine in the rabbit. Proc Soc Exp Biol Med. 140, 1385-1388.
7. Brown J.N. & Nuttall A.L. 1994. Autoregulation of cochlear blood flow in guinea pigs. Am J Physiol, 266, H458-467.
8. Canis M., Arpornchayanon W., Messmer C., Suckfuell M., Olzowy B. et al. 2010. An animal model for the analysis of cochlear blood flow [corr ected] disturbance and hearing threshold in vivo. Eur Arch Otorhinolaryngol, 267, 197-203.
9. Chen X.Y., Zhong D.F., Duan J.L. & Yan B.X. 2003. LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: Application to a pharmacokinetic study in healthy volunteers. Xenobiotica, 33, 1261-1271.
10. Dagli M., Goksu N., Eryilmaz A., Mocan Kuzey G., Bayazit Y. et al. 2008. Expression of h istamine receptors (H(1), H(2), and H(3)) in the rabbit endolymphatic sac: An immunohistochemical study. Am J Otolaryngol, 29, 20-23.
11. Dziadzio la J.K., Laurikainen E.L., Rachel J.D. & Quirk W.S. 1999. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg, 120, 400-405.
12. Fossati A., Barone D. & Benvenuti C. 2001. Binding affi nity profi le of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res, 43, 389-392.
13. Gbahou F., Davenas E., Morisset S. & Arrang J.M. 2010. Effects of betahistine at histamine H3 receptors: Mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther, 334, 945-954.
14. Goodwin P.C., Miller J.M., Dengerink H.A., Wri ght J.W. & Axelsson A. 1984. The laser Doppler: A non-invasive measure of cochlear blood flow. Acta Otolaryngol, 98, 403-412.
15. Ihler F., Bertlich M., Sharaf K., Strieth S., Strupp M. et a l. 2012. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One, 7, e39086.
16. Ihler F., Strieth S., Pieri N., Gohring P. & Canis M. 2012. Acute hyperfi brinogenemia impairs cochlear blood flow and hearing function in guinea pigs in vivo. Int J Audiol, 51, 210-215.
17. James A.L. & Burton M.J. 2001. Betahistine for Ménière ' s disease or syndrome. Cochrane Database Syst Rev, CD001873.
18. Kawakami M., Makimoto K., Fukuse S. & Takahashi H. 1991. Autoregulation of cochlear blood flow. A comparison of cerebral blood flow with muscula r blood flow. Eur Arch Otorhinolaryngol, 248, 471-474.
19. Kimura R.S. 1967. Experimental blockage of the endolymphatic duct and sac and its effect on the inner ear of the guinea pig. A study on endolymphatic hydrops. Ann O tol Rhinol Laryngol, 76, 664-687.
20. Kimura R.S. 1982. Animal models of endolymphatic hydrops. Am J Otolaryngol, 3, 447-451.
21. Klyscz T., Junger M., Jung F. & Zeintl H. 19 97. Cap image: A new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl), 42, 168-175.
22. Konzett H., Bost R.G., Bowman F.J., Bowman E.R. & McKenn is H. Jr. 1971. Betahistine, its metabolites and vascular responses in the forelimb of the dog. J Pharmacol Exp Ther, 178, 122-129.
23. Lamm K. & Arnold W. 2000. The effect of blood flow promoting drug s on cochlear blood flow, perilymphatic pO(2), and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res, 141, 199-219.
24. LaRouere M.J., Sillman J.S., Nuttall A.L. & Miller J.M. 1989. A comparison of laser Doppler and intravital microscopic measures of cochlear blood flow. Otolaryngol Head Neck Surg, 101, 375-384.
25. Laurikainen E., Miller J.F. & Pyykko I. 2000. Betahistine effects on cochlear blood flow: From the laboratory to the clinic. Acta Otolaryngol Suppl, 544, 5-7.
26. Laurikainen E., Miller J.M., Nuttall A.L. & Quirk W.S. 1998. The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol, 255, 119-123.
27. Lezius F.,Adrion C.,Mansmann U.,Jahn K.,Strupp M. 2011. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Méniè re ' s disease: A case series. Eur Arch Oto-Rhino-L. 268, 1237-1240.
28. Malinowska B., Godl ewski G. & Schlicker E. 1998. Histamine H3 receptors: General characterization and their function in the cardiovascular system. J Physiol Pharmacol, 49, 191-211.
29. Méniè re P. 1861. Congestions cerebrales apoplectiformes. Gaz md Paris, 16, 55.
30. Meyer P., Schmidt R., Grutzmacher W. & Gehrig W. 1994. Inner ear blood flow with betahistine: An animal experiment study. Laryngorhinootologie, 73, 153-156.
31. Miller J.M., Goodwin P.C. & Marks N.J. 1984. Inner-ear blood flow measured with a laser Doppler system. Arch Otolaryngol, 110, 305-308.
32. Miller J.M., Marks N.J. & Goodwin P.C. 1983. Laser Doppler measurements of cochlear blood flow. Hear Res, 11, 385-394.
33. Nakashima T., Suzuki T., Iwagaki T. & Hibi T. 2001. Effects of anterior inferior cerebel lar artery occlusion on cochlear blood flow: A comparison between laser-Doppler and microsphere methods. Hear Res, 162, 85-90.
34. Neuhauser H.K. 2007. Epidemiology of vertigo. Curr Opin Neurol, 20, 40-46.
35. Nuttall A.L. 1987. Techniques for the observation and measurement of red blood cell velocity in vessels of the guinea pig cochlea. Hear Res, 27, 111-119.
36. Pullens B., Giard J.L., Verschu ur H.P. & van Benthem P.P. 2010. Surgery for Ménière ' s disease. Cochrane Db Syst Rev.
37. Pullens B. & van Benthem P.P. 2011. Intratympanic gentamicin for Ménière ' s disease or syndrome. Cochrane Db Syst Rev.
38. Sakai K. 1980. Role of histamine H1-and H2-receptors in the cardiovascular system of the rabbit. J Cardiovasc Pharmacol, 2, 607-617.
39. Sternson L.A., Tobia A.J., Walsh G.M. & Sternson A.W. 1974. The metabolism of betahistine in the rat. Drug Metab Dispos, 2, 123-128.
40. Strupp M., Thurtell M.J., Shaikh A.G., Brand t T., Zee D.S. et al. 2011. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol, 258, 1207-1222.
41. Sun P., Takatori S., Jin X., Koyama T., Tangsucharit P. et al. 2011. Histamine H(3) receptor-mediated modulation of perivascular nerve transmission in rat mesenteric arteries. Eur J Pharmacol, 655, 67-73.
42. Thirlwall A.S. & Kundu S. 2006. Diuretics for Ménière ' s disease or syndrome. Cochrane Db Syst Rev.
43. Val L., Chen L.S., Mendes G.D. & De Nucci G. 2010. Comparative bioavailability of betahistine tablet formulations administered in healthy subjects. Arzneimi ttelforschung, 60, 440-444.
44. Woldbaek P.R., Stromme T.A., Sande J.B., Christensen G., Tonnessen T. et al. 2003. Evaluation of a new fi ber-optic pressure recording system for cardiovascular measuremen ts in mice. Am J Physiol-Heart C, 285, H2233-H2239.
45. Wu K.M. & Farrelly J.G. 2007. Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox an alysis and the role of comparative toxicology. Toxicology, 236, 1-6.